Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Lisaftoclax × Clear all

NCT03537482 2024-08-19

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms